Page last updated: 2024-10-27

gabexate and Lymphoma

gabexate has been researched along with Lymphoma in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taniguchi, N1
Kitani, T1
Kawagoe, H1
Horiuchi, A1
Masaoka, T1
Yasunaga, K1
Okamoto, Y1
Ohkubo, A1
Yonezawa, T1
Nagai, K1

Other Studies

1 other study available for gabexate and Lymphoma

ArticleYear
[Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1987, Volume: 28, Issue:10

    Topics: Aged; Aged, 80 and over; Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation; Fe

1987